Healthcare -
Biotechnology - NASDAQ - US
$ 26.33
-8.8 %
$ 2.96 B
Market Cap
-26.07
P/E
VKTX - SHORT-TERM DEBT
Short-term Debt VKTX - Viking Therapeutics, Inc.
324 K
LAST VALUE
136.35%
2 YEAR CAGR
0.00%
5 YEAR CAGR
21.32%
10 YEAR CAGR